The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.
Efficacy and safety of a recombinant hepatitis E vaccine in healthy adults: a large-scale, randomised, double-blind placebo-controlled, phase 3 trial
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lai, C. L., Ratziu, V., Yuen, M.-F., & Poynard, T. (2003) · The Lancet · doi:10.1016/s0140-6736(03)15108-2 · Cited by 1,727
Emerson, S. U., & Purcell, R. H. (2003) · Reviews in Medical Virology · doi:10.1002/rmv.384 · Cited by 785
Lu, L., Li, C., & Hagedorn, C. H. (2006) · Reviews in Medical Virology · doi:10.1002/rmv.482 · Cited by 738
Hepatitis E: An emerging awareness of an old disease
Purcell, R. H., & Emerson, S. U. (2008) · Journal of Hepatology · doi:10.1016/j.jhep.2007.12.008 · Cited by 700
Hepatitis E: an emerging infection in developed countries
Dalton, H. R., Bendall, R., Ijaz, S., & Banks, M. (2008) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(08)70255-x · Cited by 669
Safety and Efficacy of a Recombinant Hepatitis E Vaccine
Shrestha, M. P., Scott, R. M., Joshi, D. M., Mammen, M. P., Thapa, G. B., Thapa, N., Myint, K. S. A., Fourneau, M., Kuschner, R. A., Shrestha, S. K., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa061847 · Cited by 551
Persistent Carriage of Hepatitis E Virus in Patients with HIV Infection
Dalton, H. R., Bendall, R. P., Keane, F. E., Tedder, R. S., & Ijaz, S. (2009) · New England Journal of Medicine · doi:10.1056/nejmc0903778 · Cited by 547
Incidence and severity of viral hepatitis in pregnancy
Khuroo, M. S., Teli, M. R., Skidmore, S., Sofi, M. A., & Khuroo, M. I. (1981) · The American Journal of Medicine · doi:10.1016/0002-9343(81)90758-0 · Cited by 546
Aetiology, clinical course and outcome of sporadic acute viral hepatitis in pregnancy*
Khuroo, M. S., & Kamili, S. (2003) · Journal of Viral Hepatitis · doi:10.1046/j.1365-2893.2003.00398.x · Cited by 325
Kumar Acharya, S., Kumar Sharma, P., Singh, R., Kumar Mohanty, S., Madan, K., Kumar Jha, J., & Kumar Panda, S. (2007) · Journal of Hepatology · doi:10.1016/j.jhep.2006.09.016 · Cited by 308
Cited by
Bioengineering virus‐like particles as vaccines
Lua, L. H. L., Connors, N. K., Sainsbury, F., Chuan, Y. P., Wibowo, N., & Middelberg, A. P. J. (2014) · Biotechnology and Bioengineering · doi:10.1002/bit.25159 · Cited by 355
Platforms for Production of Protein-Based Vaccines: From Classical to Next-Generation Strategies
Cid, R., & Bolívar, J. (2021) · Biomolecules · doi:10.3390/biom11081072 · Cited by 176
Pregnancy and infection: using disease pathogenesis to inform vaccine strategy
Vermillion, M. S., & Klein, S. L. (2018) · npj Vaccines · doi:10.1038/s41541-017-0042-4 · Cited by 39
Metadata
- Authors
- Zhu, F.-C., Zhang, J., Zhang, X.-F., Zhou, C., Wang, Z.-Z., Huang, S.-J., Wang, H., Yang, C.-L., Jiang, H.-M., Cai, J.-P., Wang, Y.-J., Ai, X., Hu, Y.-M., Tang, Q., Yao, X., Yan, Q., Xian, Y.-L., Wu, T., Li, Y.-M., Miao, J., Ng, M.-H., Shih, J. W.-K., & Xia, N.-S.
- Venue
- The Lancet
- Publisher
- Elsevier BV
- Published
- 2010-09
- Volume
- 376
- Issue
- 9744
- Pages
- 895-902
- ISSN
- 0099-5355 (ISSN-L)
- 0140-6736
- OpenAlex
- W2136175711
- Cited by
- 803
- References
- 15
- FWCI
- 29.16
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Efficacy and safety of a recombinant hepatitis E vaccine in healthy adults: a large-scale, randomised, double-blind placebo-controlled, phase 3 trial. https://app.cochat.ai/papers/10.1016/s0140-6736(10)61030-6
- The paper
- Zhu, F.-C., Zhang, J., Zhang, X.-F., Zhou, C., Wang, Z.-Z., Huang, S.-J., Wang, H., Yang, C.-L., Jiang, H.-M., Cai, J.-P., Wang, Y.-J., Ai, X., Hu, Y.-M., Tang, Q., Yao, X., Yan, Q., Xian, Y.-L., Wu, T., Li, Y.-M., . . . Xia, N.-S. (2010). Efficacy and safety of a recombinant hepatitis E vaccine in healthy adults: a large-scale, randomised, double-blind placebo-controlled, phase 3 trial. The Lancet. https://doi.org/10.1016/s0140-6736(10)61030-6
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.